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Abstract 
 
A central goal of synthetic biology is to engineer cellular behavior by engineering 
synthetic gene networks for a variety of biotechnology and medical applications. The 
process of engineering gene networks often involves an iterative ‘design-build-test’ 
cycle, whereby the parts and connections that make up the network are built, 
characterized and varied until the desired network function is reached. Many advances 
have been made in the design and build portions of this cycle. However, the slow 
process of in vivo characterization of network function often limits the timescale of the 
testing step. Cell-free transcription-translation (TX-TL) systems offer a simple and fast 
alternative to performing these characterizations in cells. Here we provide an overview 
of a cell-free TX-TL system that utilizes the native Escherichia coli TX-TL machinery, 
thereby allowing a large repertoire of parts and networks to be characterized. As a way 
to demonstrate the utility of cell-free TX-TL, we illustrate the characterization of two 
genetic networks: an RNA transcriptional cascade and a protein regulated incoherent 
feed-forward loop. We also provide guidelines for designing TX-TL experiments to 
characterize new genetic networks. We end with a discussion of current and emerging 
applications of cell free systems.  
 
Keywords: cell-free systems, transcription-translation (TX-TL), rapid prototyping, 
genetic networks, synthetic biology 
 
Abbreviations: TX-TL (transcription-translation), I1-FFL (incoherent feed-forward loop 
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1. Introduction 
 
Cells have a remarkable ability to sense and process information about their 
external environment and their internal physiological state. They use this ability to adapt 
to constantly changing environments by making genetic decisions that control their 
behavior. These decisions range from selectively expressing metabolic enzymes that 
can produce a wide array of products, to altering motility patterns and differentiating 
their cell state. Harnessing and manipulating this diversity of cell behavior is thus a core 
aspect of many biotechnologies. These biotechnologies include engineering cells to 
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make products from renewable feedstocks [1,2], using cells as new therapeutic agents 
[3], and many others. 
The natural ability of cells to control their behavior is encoded in genetic networks 
– interconnected webs of regulatory molecules that control gene expression in defined 
patterns. These genetic networks, or circuits, take internal and external signals as 
inputs, and shape the flow of genetic information through gene expression. In this way, 
genetic networks ultimately act as one of the core information processing units of the 
cell [4]. Because of this, our ability to engineer cellular behavior is directly related to our 
ability to engineer genetic networks, which is a central goal of synthetic biology [5-7].  
There has been a great deal of interest in developing systematic and efficient 
methods for engineering genetic networks with predictable behaviors [5,8]. Because of 
the influences from other engineering disciplines, synthetic biologists often think of 
engineering genetic networks in terms of iterative ‘design-build-test’ cycles. A design-
build-test cycle typically entails: designing DNA sequences that encode genetic 
regulatory ‘parts’ and their interconnections, building these DNA sequences in 
expression constructs, and testing the performance of the parts and networks in cells by 
monitoring the expression of detectable outputs. Recently, there has been rapid 
progress in both the design and build aspects of this cycle. Specifically, there are a 
number of new computational tools that can facilitate the design of genetic regulators [9-
13]. There are also a plethora of high-throughput and high-fidelity DNA synthesis and 
assembly techniques that can be used to build, or even commercially order, DNA that 
encodes whole genetic networks [14-21]. However, progress has lagged in establishing 
reliable and efficient methods for testing these networks, making the testing step the 
current bottleneck in engineering and optimizing gene networks. 
Two aspects of testing genetic networks in cells make this process slow and 
complex. First, DNA elements must be configured in compatible formats, such as 
different plasmid systems, which imposes constraints on the physical assembly and 
relative expression levels of each network part. Second, the process of incorporating 
this DNA into cells, for example by transformation, selection, and subculturing, takes 
several days, which delays characterization. Cell-free systems directly address these 
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limitations, and offer an alternative approach for characterizing outputs of genetic 
networks in a simplified in vitro environment that closely mimics the cell [22-28].  
Cell-free systems typically consist of a cell lysate or purified 
transcription/translation machinery and a buffer/energy mix optimized to express genes 
from template DNA. The utility of cell-free systems was first realized in the 1960’s when 
lysates were used to translate defined synthetic RNAs into proteins leading to the 
elucidation of the genetic code [29]. Since then, protein production has continued to be 
the major use of E. coli cell-free systems, though early applications were limited due to 
short-lived reactions and low protein yield [30-32]. This motivated a number of 
optimizations in energy source and energy regeneration [30,31,33-37] as well as the 
development of new E. coli strains that were engineered to stabilize amino acids [38] 
and improve protein expression from PCR products [39,40]. At the same time, 
preparation of crude extract was simplified [31,36,41], and alternate cell-free expression 
systems were developed by reconstituting in vitro transcription and translation from 
purified components [42]. These advancements have not only improved protein 
production, but have also allowed new applications such as the production of proteins 
with unnatural amino acids [43-46]. 
Building off of this rich history, researchers have now begun to leverage the 
flexibility of cell-free systems to express entire genetic networks for their functional 
characterization. A major advantage of cell-free systems for network characterization 
lies in their cell-free nature: testing cycles can be decoupled from the DNA formatting 
and transformation/cell growth issues that have hampered traditional network 
characterization. This has the effect of removing complications associated with ensuring 
that the DNA encoding the networks are on compatible plasmid origin and antibiotic 
resistance constructs. In fact, recent innovations have made it possible to test genetic 
networks constructed on linear PCR products, enabling the testing cycle to be directly 
coupled to high-throughput design and construction techniques [47]. 
In addition, cell-free systems decouple the experiment from cell growth, which 
allows an order of magnitude decrease in testing times, going from a typical three day 
experiment for testing in bacterial cells to a mere three hour experiment with cell-free 
systems [22]. Cell-free systems are also convenient because they are open reactions. 
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This allows flexibility in experimental design as well as control of the biochemical and 
biophysical components of the reactions. In addition, cell-free systems are opening the 
door to new types of applications, such as new molecular diagnostics which use TX-TL 
reactions to detect the presence of analytes in solutions [48]. Finally, because of their 
ease-of-use and rapid turnaround times, cell-free systems are finding new uses as 
teaching tools for synthetic biology through hands-on experiments [28]. 
The advantages and flexibility of cell-free systems have prompted recent efforts 
to develop a cell-free system that closely mimics the characteristics of the live cell 
environment. Such a system would enable the rapid prototyping of genetic networks for 
eventual deployment in the cell. Because the original focus of cell-free systems was on 
protein expression and maximizing protein yields, bacteriophage polymerases and 
promoters, such as T7, were used due to their high levels of transcription and 
specificity. Recently, an all E. coli cell-free transcription-translation (TX-TL) expression 
system was shown to be as efficient as the bacteriophage systems [23]. This system 
has all of the benefits of bacteriophage hybrid cell-free systems, but instead it only uses 
the native E. coli TX-TL machinery and recapitulates the seven-E. coli sigma factor 
transcription scheme. Consequently, the repertoire of regulatory elements that can be 
used is expanded to hundreds of parts rather than just variants of a single 
bacteriophage promoter. Multiple stage cascades, logic gates, negative feedback loops 
and other networks have been characterized with this system [49], which can be used in 
test tube reactions, microfluidics and liposomes [50]. In addition, methods to tune 
mRNA and protein degradation rates have been devised for this system [51], enabling 
even finer grained control over genetic network performance. Thus the E. coli cell-free 
TX-TL platform holds great promise as a toolbox for rapid testing and optimization of a 
large array of regulatory networks. 
In this article we focus on the all E. coli cell-free TX-TL system [49]. We explain 
its versatility, its current capabilities and limitations. We start by providing general 
guidelines for executing TX-TL reactions by describing two examples where TX-TL 
reactions were used to characterize genetic parts and networks. We then discuss 
important considerations for a new user designing their own TX-TL experiments. Finally, 
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we end by discussing current applications and potential avenues for cell-free TX-TL 
systems.  
 
2. Basic TX-TL preparation and experiment 
 
The all E. coli cell-free TX-TL expression system was first developed by 
modifying existing E. coli S30 extract protocols [31,41] to create an in vitro gene 
expression system optimized for examining the dynamics of genetic networks driven by 
E. coli promoters [49]. The system combines crude E. coli lysate with a buffer mixture 
containing resources necessary for transcription and translation. The lysate is 
generated by bead-beating cell resuspensions from BL21 Rosetta2 cell cultures, 
however cell strain and lysis method can be optimized to meet individual needs [52]. 
The buffer contains protein and RNA building blocks (twenty natural amino acids, 
NTPs), tRNAs, an energy regeneration system composed of a phosphate donor such as 
phosphoenolpyruvate (PEP), as well as multiple other small molecules. Additional 
molecules can be added for specific effects. For instance, the protein GamS can be 
added to prevent the degradation of linear double-stranded DNA templates, while the 
protein complex ClpXP can be added to increase the degradation of ssrA-tagged 
proteins [47,53,54]. A detailed protocol for preparing both crude extract and buffer, as 
well as for setting up and running a TX-TL experiment, is described by Sun et al. [22]. 
 A basic TX-TL experiment consists of adding DNA encoding a genetic regulator 
or network suspended in water, into a mixture of extract and buffer (Figure 1) [22]. Both 
plasmid DNA and linear PCR products can be used, though linear DNA will be 
degraded by endogenous exonucleases present in the extract unless the exonuclease 
inhibitor GamS is added (see Section 5.2). The volume of a typical TX-TL reaction is 10 
µL, with DNA added in concentrations ranging from 0.01 to 20 nM depending on 
expression strength. The network being tested can consist of one or multiple DNA 
constructs, with at least one regulatory output designed to produce a measurable signal, 
such as a fluorescent reporter protein (e.g. GFP). After DNA is added to the buffer and 
extract, the mixture is typically incubated either at 29oC or 37oC, and the fluorescence 
output measured over time. For endpoint measurements, the mixture is often placed in 
a microcentrifuge tube and kept in an incubator for 1-8 hours before being transferred 
. CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/019620doi: bioRxiv preprint first posted online May. 21, 2015; 
	   7	  
into a microplate and measured on a plate reader. Most experiments described in this 
article use a 10 µL total reaction volume, placed in a 384-well microplate and measured 
for 1.5-8 hours on a Biotek plate reader. While we use 10 µL for convenience, TX-TL 
reactions can be run at larger volumes as long as they are properly oxygenated.  
 
 
Figure 1. Characterizing genetic networks in TX-TL reactions. Networks or parts are tested in TX-TL 
reactions by mixing the DNA for a given network with TX-TL extract and energy mix. Characterization 
typically begins with a titration of the DNA that controls the reporter protein expression. A plot of 
measured endpoint fluorescence versus the input DNA concentration is useful to determine the 
expression capacity of the TX-TL system and typically shows two regimes: a linear response up to a few 
nM of DNA template, and then saturation due to TX-TL molecular machinery depletion. Once reporter 
DNA concentration is chosen, the remaining parts of the network can be titrated and characterized. 
 
3. How to characterize a genetic network in TX-TL 
 
 While the basic setup of a single TX-TL reaction is straightforward, there are 
several steps that we have found to be useful when characterizing a new regulatory part 
or network in the TX-TL system. To start, we have found that network characterization is 
most easily and rapidly carried out when fluorescent proteins are used to report on the 
gene expression outputs of the network. When choosing fluorescent reporter proteins it 
is important to consider maturation times and it is best to choose fluorescent proteins 
with faster and comparable maturation times. Other techniques, such as electrophoresis 
(SDS PAGE) to measure protein output, or FRET-based probes [55], can be used for 
quantification, but they are either more time consuming, or require the use of 
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specialized TX-TL systems [56]. After deciding on a characterization method, the next 
step is to construct the DNA that encodes the network elements. We have found that it 
is easiest to encode each part of the network on separate plasmids or DNA elements 
(see Section 5.2 for guidelines). This allows both ease of assembly and additional 
flexibility for optimizing network function.  
Once the DNA parts have been assembled, we typically start the network 
characterization process by titrating the concentration of the DNA that controls the 
reporter protein expression, and characterizing its output. A plot of the measured 
endpoint fluorescence versus the input DNA concentration is useful to determine the 
expression capacity of the TX-TL system and typically shows two regimes: a linear 
response up to a few nM of DNA template, and then saturation due to TX-TL molecular 
machinery saturation (Figure 1). This curve also allows the user to choose a template 
concentration that balances signal to background, while minimizing the DNA input to 
allow the addition of other network elements (see Section 5.3 for resource limitations). 
From here, we titrate other network elements to test the effect of varying the 
concentration ratios of these elements on overall network function. Fluorescence versus 
time plots are collected in order to evaluate the dynamics of gene expression for the 
network. We also use knowledge of previously tested in vivo elements, such as relative 
plasmid copy number, to choose starting points for DNA concentrations. Results are 
typically presented as either production rates from raw fluorescence data [25,28] 
(Section 3.1) or as protein concentrations using a calibration curve generated from 
purified fluorescent protein [23,47,49] (Section 3.2). We now demonstrate this approach 
in the context of two example genetic networks – an RNA transcriptional cascade 
[28,57] and a protein regulated feed-forward loop.  
 
3.1 RNA network example 
 
As an example of how to use the all E. coli TX-TL system to test RNA genetic 
networks, we will describe the steps taken to characterize an RNA transcriptional 
cascade [28,57]. The central element of this cascade is an RNA-mediated 
transcriptional repressor, engineered from the pT181 transcriptional attenuator [58,59]. 
The attenuator lies in the 5’ untranslated region of the gene it regulates, and functions 
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like a transcriptional repressor, either allowing (ON) or preventing (OFF) elongation of 
RNA polymerase through the transcript [58,59]. The OFF state is induced by an RNA-
RNA interaction between the attenuator and a complementary antisense RNA, which is 
expressed in trans in this synthetic context (Supplementary Figure S1). By 
transcriptionally fusing the pT181 repressor to the coding sequence for super folder 
green fluorescent protein (SFGFP) [60], the function of the repressor can be 
characterized by measuring SFGFP fluorescence with and without antisense RNA 
present. A second, mutated version of the repressor, engineered to be orthogonal to the 
wild type repressor, enables the configuration of a double-repression transcriptional 
cascade that functions in E. coli [57]. 
In order to characterize this RNA transcriptional cascade with TX-TL reactions, 
the first step was to test the function of the wild type pT181 repressor. To do this, the 
basic repression system was configured on two separate plasmids – one containing the 
expression cassette for the attenuator target region fused to SFGFP (reporter level), 
and the other containing the expression cassette for the antisense RNA (Figure 2A, 
Supplementary Figure S2). From here, the concentrations of plasmid DNA containing 
the attenuator (Att-1) and antisense (AS-1) RNAs were titrated in different TX-TL 
reactions to achieve a repression in TX-TL reactions comparable to that found in vivo 
[28] (Figure 2A-C). Attenuator plasmid concentrations were varied between 0.25 nM 
and 1 nM, while antisense plasmid concentrations were varied between 4 nM and 16 
nM (Supplementary Figure S3). Since SFGFP is very stable and not degraded in TX-TL 
reactions, an increase in fluorescence over time is always observed due to imperfect 
repression even in the (+) antisense conditions. Because of this, and resource depletion 
effects that occur in TX-TL reactions [22], end point fluorescence measurements can be 
misleading [25]. Therefore network performance was characterized by quantifying 
SFGFP production rates that are calculated as the slope between consecutive time 
points in the fluorescence time course data [25]. In particular, these calculations are 
typically done at the beginning of the time courses (up to 2 hours) when nutrients 
(nucleotides, amino acids) are not limiting. From these rates, windows of constant 
maximum protein production for each trajectory were found, averaged over several 
replicate experiments, and compared to assess overall gene repression in the TX-TL 
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reactions (Figure 2B-C) [28]. We note that the region of maximum protein production 
occurs at different times between the with and without antisense RNA reactions. 
Furthermore, the with antisense RNA production rate decreases ~ 40 min after the 
maxima is reached. One reason for this decrease could be due to resource depletion 
caused by the RNA-RNA interactions triggering additional RNA degradation pathways. 
Alternatively, this could be a result of the slow degradation of Att-1-SFGFP transcripts 
that escape attenuation at the start of the reaction. Independent of a specific cause, we 
use the region of maximum production rate as a conservative estimate of attenuator 
repression [28]. These titrations led to a final concentration of 0.5 nM attenuator and 8 
nM antisense plasmids. 
Next, the function and orthogonality of the mutated version of the pT181 
attenuator [57] (Att-2, AS-2) was tested in the TX-TL system. Orthogonality was 
assessed by comparing average SFGFP production rates for reactions of each 
attenuator with a no-antisense control (used as a resource utilization control, see 
Section 5.3), its cognate antisense, or the non-cognate antisense using DNA plasmid 
concentrations found from the experiments described above. For each attenuator, 
cognate antisense RNAs caused repression while non-cognate antisense RNAs 
resulted in SFGFP production rates that were within error of the no-antisense control, 
thus confirming orthogonality in TX-TL (Figure 2D) [28]. 
These parts then allowed for the characterization of the full RNA transcription 
cascade that combined these two elements together (Figure 2E) [28,57]. In this 
configuration, the bottom level of the cascade (L1) contains the wild type pT181 
attenuator (Att-1), which regulates the expression of SFGFP expression via its 
interaction with its cognate antisense (AS-1). The production of AS-1 is in turn regulated 
by the mutant pT181 attenuator (Att-2) on the second level of the cascade (L2) through 
its interaction with AS-2, which is transcribed on level three of the cascade (L3) (Figure 
2E). DNA concentrations for the three elements of the cascade were titrated for optimal 
performance [28], with the final result shown in Figure 2F. The presence of just L1 
results in high SFGFP production. A combination of L1 and L2 leads to repression of 
Att-1, thus lower SFGFP production. Finally, a combination of L1, L2, and L3 results in a 
double inversion leading to high SFGFP production (Figure 2F) and confirmation of a 
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functional RNA transcription cascade in the TX-TL system. The characterization of the 
three level cascade, once DNA was prepared, required five TX-TL experiments, each 
completed in three hours. 
 
Figure 2. Characterizing an RNA transcriptional cascade in TX-TL reactions. (A) Fluorescence time 
courses of TX-TL reactions containing the pT181 attenuator reporter plasmid at 0.5 nM, with 8 nM 
antisense plasmid (+) or 8 nM no-antisense control plasmid (-). Colored circles represent the different 
plasmids in the system; the antisense (red) represses (blunt end line) the attenuator-SFGFP target (blue). 
(B) SFGFP production rates were calculated from the data in (A) by calculating the slope between 
consecutive time points. Boxes represent regions of constant SFGFP production. Blue and red shaded 
regions in (A) and (B) represent standard deviations of at least seven independent reactions performed 
over multiple days calculated at each time point. (C) Average SFGFP production rates were calculated 
from the data in boxed regions in (B). Error bars represent standard deviations of those averages. The (+) 
antisense condition shows 72% repression compared to the (-) antisense condition in TX-TL reactions. 
(D) Orthogonality of the pT181 attenuator (Att-1) to a pT181 mutant attenuator (Att-2). Average SFGFP 
production rates were calculated as in (C). Bars represent each attenuator at 0.5 nM with 8 nM of no-
antisense control plasmid (blue), pT181 antisense plasmid (AS-1, red), or pT181 mutant antisense 
plasmid (AS-2, purple). (E) Schematic of an RNA transcriptional cascade. L1 is the same pT181 
attenuator (Att-1) reporter plasmid used in (A) – (D). In the plasmid for L2, the pT181-mut attenuator (Att-
2) regulates two copies of the pT181 antisense (AS-1), each separated by a ribozyme (triangle) [57]. The 
L3 plasmid transcribes the pT181-mut antisense (AS-2). Colored circles represent the different plasmids 
in the system with blunt end lines showing the repressive connections of the cascade. (F) Average 
SFGFP production rates for the three combinations of the transcription cascade levels depicted in (E). L1 
alone (blue bar) leads to high SFGFP production. L1+L2 (red bar) results in AS-1 repressing Att-1, thus 
lower SFGFP production. L1+L2+L3 (purple bar) results in a double inversion leading to high SFGFP 
production. Total DNA concentration in each reaction was held constant at 18.5 nM. In (D) and (F) error 
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bars represent standard deviations from at least seven independent reactions performed over multiple 
days. Figure from Takahashi et al. ACS Synth. Biol., 4 (2015) 503-515 [28]. 
 
3.2 Protein network example 
The steps taken to test protein-mediated networks in the TX-TL system are 
similar to those for RNA-mediated networks, with a few protein-specific additions.  For 
instance, while RNAs are readily degradable by RNases within the extract, there is often 
not enough protein degradation machinery native to the extract to significantly degrade 
expressed protein.  Protein degradation rate can be greatly increased by the addition of 
the protease ClpXP, either on DNA or as a purified protein. Any proteins that require 
degradation must be expressed with a degradation tag specific to ClpXP [61] 
(Supplementary Figure S4). Another difference between RNA and protein-mediated 
networks is that proteins take a longer time to express than RNAs because of the 
additional steps of translation and protein folding. The amount of time needed is protein 
specific and generally on the order of minutes. Consequently, proteins take longer than 
RNAs to reach the concentration thresholds needed to be active in the specific network 
tested [62]. 
 As an example of how to test protein regulated networks in the TX-TL system, we 
will explain how we prototyped an incoherent type-1 feed-forward loop (I1-FFL) [63]. 
Our version of the I1-FFL consists of three “transcription units” (TU, promoter through 
terminator), each on its own plasmid (Figure 3A). The first unit (TU1) encodes the gene 
for sigma-28 (rpoF), constitutively expressed by an E. coli promoter specific to sigma-
70. In vivo, sigma-28 is related to flagellum formation [64]; however in TX-TL, sigma-28 
acts as an activator for any gene downstream of the sigma-28 dependent promoter Ptar 
[49]. The second unit (TU2) encodes the protein transcriptional repressor TetR, 
downstream of Ptar. TetR sterically represses transcription of promoters containing the 
tetO operator [65]. The third unit (TU3) encodes the fluorescent reporter GFP (green 
fluorescent protein) downstream of a rationally designed Ptar-tetO hybrid promoter. This 
promoter is activated by sigma-28 and repressed by TetR.  
The I1-FFL functions as follows. At time zero, all promoters are off except for the 
constitutive promoter, which starts transcription of sigma-28. After translation, sigma-28 
together with RNA polymerase binds to and initiates transcription of both Ptar promoters 
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on units TU2 and TU3. This results in the simultaneous transcription and then 
translation of TetR and GFP, and an initial increase in measured fluorescence. 
However, over time TetR accumulates in the system, and eventually reaches a 
concentration sufficient to shut down GFP production from TU3. In the TX-TL system 
with minimal native protein degradation, this results in the fluorescent signal plateauing 
at a constant value. If ClpXP is added to TX-TL reactions, the output is a pulse of 
measured fluorescence over time (Figure 3A). 
 To prototype the I1-FFL in the TX-TL system, the first step was to determine 
optimal sigma-28 DNA (TU1) and reporter DNA (TU3) concentrations for in vitro testing. 
The concentration of reporter DNA was varied between 0.5 and 2 nM, and the 
concentration of sigma-28 DNA was varied from 0 to 2 nM (Figure 3B). To obtain 
maximum signal, fluorescence was measured at 8 hours, when the reactions had 
plateaued.  The results show that i) the previously untested Ptar-tetO hybrid promoter 
successfully produces GFP in the presence of sigma-28, ii) the hybrid promoter’s 
leakiness is negligible, with very little GFP produced in the absence of sigma-28, and iii) 
that while all non-zero concentrations of sigma-28 and reporter DNA tested are 
sufficient to produce fluorescent signal, both 0.2 and 2 nM of sigma-28 DNA result in 
significantly higher signal than 0.02 nM. (Figure 3B). To avoid saturating the system 
with unnecessary DNA, we chose to use 0.2 nM of sigma-28 DNA for future 
experiments. In addition, the results show that adding 2 nM of reporter DNA gives less 
than twice the signal of 1 nM reporter DNA, indicating that the TX-TL molecular 
machinery is starting to become saturated at 2 nM of reporter DNA. We therefore chose 
to use 1 nM of reporter DNA, as it gives relatively high signal and does not saturate the 
TX-TL machinery.  
 The second step was to explore the effect of TetR DNA concentration on GFP 
output. Setting reporter DNA (TU3) concentration constant at 1 nM and sigma-28 DNA 
(TU1) at 0.2 nM, we varied TetR DNA (TU2) from 0 to 1 nM (Figure 3C). The results 
show that i) the novel Ptar-tetO hybrid promoter is repressed by TetR and thus functions 
as designed, ii) the TU2 Ptar promoter produces sufficient TetR to repress GFP 
production, and iii) that even a very small amount of TetR DNA (0.001 nM) is sufficient 
to decrease signal. Since our aim was to prototype an I1-FFL, we wanted to choose a 
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TetR concentration that significantly represses signal, but not so strongly that the signal 
falls into the noise range of our instruments and becomes difficult to detect. Therefore, 
we chose to use 0.01 nM of TetR DNA, which decreases signal more than 2-fold but still 
gives us more than 1 µM of fluorescent protein.  
 The third step was to determine if the network would exhibit a pulse-like signal in 
TX-TL when protein degradation machinery was added. To test this, reporter (TU3), 
sigma-28 (TU1), and TetR (TU2) DNA concentrations were set at 1, 0.2 and 0.01 nM, 
respectively. DNA encoding ClpXP was added in concentrations ranging from 0 to 2 nM 
(Figure 3D). The results showed that i) ClpXP successfully degraded the degradation-
tagged GFP protein, ii) the addition of 0.5 nM ClpXP resulted in a small pulse, 
characteristic of the I1-FFL, and iii) that adding ClpXP DNA to the system significantly 
decreases maximum signal. 
 Overall, characterization of the I1-FFL in the TX-TL system required only three 
experiments, each completed in less than a day.  We were able to rapidly test different 
concentrations of the circuit transcriptional units to determine what ratios result in 
successful I1-FFL pulse-like behavior, a test which in vivo would have required varying 
plasmid copy numbers or swapping in different strength promoters or ribosomal binding 
sites.  Additionally, because TX-TL reactions are entirely in vitro, we were able to test a 
non-traditional “activator,” sigma factor 28, without potential in vivo side effects such as 
flagellum activation and toxicity. 
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Figure 3. Characterizing a protein-mediated incoherent feed-forward loop. (A) Schematic of an 
incoherent type-1 feed-forward loop (I1-FFL). Transcription unit 1 (TU1) constitutively expresses sigma-28 
(σ28), which activates the expression of both transcription unit 2 (TU2) and transcription unit 3 (TU3). TU2 
produces the TetR repressor protein, which represses the production of GFP from TU3. The simultaneous 
activation of TU2 and TU3 results in a pulse of GFP when the protease ClpXP is present to degrade the 
GFP signal. (B) Average measured GFP concentration for TX-TL reactions with varying TU1 (0–2 nM) for 
three different TU3 concentrations (0.5, 1, 2 nM) at 8 hours of reaction time. Error bars represent 
standard deviations from three independent reactions. The bars corresponding to the 0 nM TU1 reactions 
are not visible on this scale. Average concentrations were 3, 5, and 8 nM GFP for 0.5, 1, and 2 nM TU3, 
respectively. (C) Average measured GFP concentration for 1 nM TU3, 0.2 nM TU1, and varying TU2 DNA 
from 0-1 nM at 8 hours of reaction time. Error bars represent standard deviations from three independent 
reactions. (D) Full I1-FFL with added ClpXP DNA. Plot of measured GFP concentration over time with 1 
nM TU3, 0.2 nM TU1, 0.01 TU2, and varying ClpXP DNA from 0-2 nM. Each result represents the 
average of two independent TX-TL reactions. The TX-TL experiments for figure 3D were run with a 
different extract batch from figures 3B and 3C, so the protein concentrations are not directly comparable. 
 
4. Using spike experiments to measure responses to network perturbations  
The openness of TX-TL reactions enables a great deal of flexibility in 
experimental design. In particular, the lack of a cell membrane enables the addition of 
new DNA constructs, small molecules such as inducers, and macromolecules such as 
transcription factors at any point during an experiment. These ‘spike’ additions, coupled 
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with frequent monitoring of network output on a microplate reader, allows for the 
determination of network response times to the addition of a new species and more 
broadly dynamic perturbations of network conditions. In fact, ligand response times 
measured using TX-TL reactions have been shown to be relevant to similar response 
times measured in vivo (Section 5.7). This demonstrates that TX-TL spike experiments 
can be used to rapidly test network perturbations for in vivo use. 
DNA spike experiments were recently used to measure the response time of the 
RNA transcription cascade described in Section 3.1 (Figure 2E) to the addition of the L3 
antisense RNA [28]. The L3 antisense RNA (AS-2) triggers the double inversion of the 
cascade. Therefore, its addition to a reaction only containing the bottom two levels of 
the cascade should cause an increase in the fluorescence trajectory for the reaction. 
Fluorescence trajectories for reactions with and without the addition of L3 were 
compared to determine the time at which the trajectories diverge. This gives a measure 
of the network response time to the addition of L3. To measure this, TX-TL reactions 
with 0.5 nM L1 and 4 nM L2 were setup and allowed to proceed for 20 min in the 
microplate, at which point 14 nM of either L3 or a no-antisense control plasmid was 
spiked into the reactions on the microplate using a multi-channel pipette (t=0). 
Reactions were placed back on the microplate reader and fluorescence monitored every 
minute. The fluorescence trajectories showed that the L3 spike differed from the control 
approximately 15 min after the spike (Supplementary Figure S5). A Welch’s t-test was 
used to determine the point at which the two trajectories were significantly different 
across multiple experimental replicates (14.6 ± 4.8 min – Supplementary Figure S5) 
[28]. This represents the response time of the cascade to the addition of L3 DNA. 
Similar response times can be measured in this way for other protein or RNA networks, 
inducible promoters, aptamer constructs, etc.  
There are a few important considerations when designing/performing spike 
experiments: (i) An appropriate control reaction should be designed to maintain equal 
volumes and equal total amounts of DNA in reactions that will be compared. In the RNA 
cascade example the total DNA concentration in each reaction was especially important 
(see section 5.4), therefore a no-antisense control was added in parallel. (ii) When 
performing the actual spike addition, it is important to avoid addition of bubbles to the 
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reaction wells. If bubbles are present after the spike, the data should be discarded and 
additional replicates performed. (iii) If the response time for the experiment is expected 
to be fast, it is best to use a multichannel pipette to add elements to multiple reactions 
at the same time. 
 
5. Important considerations 
5.1 Batch to batch variation 
As described earlier, the TX-TL system is a combination of S30-like cell free 
lysate, buffer solution, and DNA. We define batch-to-batch variation as variability that 
results when the lysis method and buffer solution is held constant to a set protocol. In 
lieu of characterizing individual components in the extract, we broadly determine this 
variability using a plasmid that strongly expresses GFP. While all extracts express the 
plasmid, they can differ in the dynamics and strength of expression (Figure 4A).  
Theoretically, lysates made using the same strain and following the same 
preparation protocol will have the same expression dynamics. However, in practice 
there can be significant variability depending on the person preparing the extracts and 
factors intrinsic to the process but hard to control for, such as the exact optical density 
(OD) the cells are captured in at mid-log phase, time cells are on ice, or lysis efficiency. 
Additionally, due to the buffer being composed of at least 25 ingredients, different buffer 
preparations may have slight variations in reagent concentrations. Therefore, we define 
a combination of a similarly prepared lysate and buffer as a “batch” and conduct all 
experiments within this batch. Due to batch-to-batch variation, experiments from 
different batches are generally not directly comparable, though results can often be 
correlated. 
Our typical extract uses a commercial strain of BL21-Rosetta2. However, lysates 
have been made from multiple strains of E. coli such as BL21-type, Rosetta2-type, 
JM109-type, MG1655-type, DE3-expressing and custom variants [52]. To date, all of the 
strains have been usable for prototyping. However, protein-expressing ability seems to 
be partially dependent on strain. 
Variability can also result from the processes used to prepare the materials.  
There are many lysis methods that can be employed, such as mechanical lysis with 
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bead-beating [22,23], microfluidizing [35], and sonication [52,66]. There are also 
different types of buffering solutions, each using independent energy sources [30,33-
35,37,67]. There is limited work, however, on evaluating the ability of these extract 
variants to conduct gene network prototyping. 
 
 
Figure 4. Batch-to-batch variation. (A) Batch-to-batch variation demonstrated by the expression of 1nM of 
a strong deGFP-expressing plasmid using seven disparate batches composed of extracts and buffers 
prepared by different people on different days. (B) RNase batch-to-batch variation. Average maximum 
SFGFP production rates from three different buffer and extract preparations using 0.5 nM L1 and 0, 5, 10, 
15, and 20 nM no-antisense control DNA from the RNA transcriptional cascade (Figure 2). Error bars 
represent standard deviations from at least 11 independent reactions. Batches in (B) were not the same 
as in (A). Part (B) adapted from Takahashi et al. ACS Synth. Biol., 4 (2015) 503-515 [28]. 
 
5.2 DNA preparation 
 DNA inputs for cell-free reactions can be plasmid DNA and linear or circularized 
[25] PCR products, though there are specific considerations for each type of input. For 
plasmid DNA, a pure and well-supercoiled solution in a low-salt buffer is ideal. As 
mentioned previously, there are no limitations on compatibility of plasmid origins or 
antibiotic resistance.   
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An advantage to using linear DNA to prototype new parts and networks is that it can 
be constructed via a rapid DNA assembly method such as Golden Gate assembly [14]. 
In this way, a new network construct can be assembled and PCR amplified for use in a 
TX-TL reaction without going through in vivo selection and purification [47]. TX-TL 
extract contains endogenous DNA exonucleases, making it important to include a 
truncated version of the bacteriophage Gam protein, GamS, (3.5 µM in the final 
reaction) in the reactions to protect linear DNA from degradation [47,53]. In addition, 
adding 250 bases of steric protection (non-coding DNA sequence) to each end of the 
linear construct can further slow degradation.  
It is important to note that transcriptional promoters can function differently in TX-TL 
reactions depending on whether linear or plasmid DNA templates are used [25,47]. 
Such variation has been hypothesized to be due to differences in preparation of DNA 
templates [47] as well as conformational differences such as supercoiling between 
linear and plasmid DNA  [25,47]. Two methods for correcting this difference have been 
suggested. First, linear DNA templates can be circularized using a USER-ligase 
reaction. The circularized templates have been shown to be comparable to plasmid 
templates in TX-TL reactions [25]. Limitations are extra processing time and the 
relatively low efficiency of the circularization reaction. One alternative is to characterize 
the difference between the expression profiles of a given regulator on circular and linear 
DNA templates, and calibrate characterization data accordingly [47].  
 
5.3 Resource limitations/usage 
Most cell-free TX-TL reactions are performed in batch mode, i.e. in a fixed 
volume much larger than a cell (typically 10 µl), using a diluted cytoplasmic extract. A 
direct consequence of this setup is resource limitations at two levels: (i) fixed 
concentrations of nutrient resources (NTPs, amino acids, etc.), which limit the lifetime of 
reactions, and (ii) fixed concentrations of the core TX-TL machinery, which limit the rate 
of RNA and protein synthesis. 
In terms of nutrient resources, translation places some of the highest demands 
on chemical energy usage since two ATP and two GTP are consumed per peptide bond 
formed. In modern cell-free TX-TL systems, batch mode reactions terminate because of 
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chemical energy limitations and accumulation of byproducts. Therefore, most of the 
effort to increase cell-free protein expression is spent on developing new metabolisms 
to energize translation, which consists of devising methods to i) maintain ATP and GTP 
concentrations at their initial concentrations (about 1-2 mM), ii) regenerate ADP and 
AMP, and iii) recycle reaction byproducts such as inorganic phosphate, which is a 
strong inhibitor of protein synthesis. An ATP regeneration system composed of a 
phosphate donor (for example, creatine phosphate) and a kinase is also added to the 
energy mixture. Such a system extends gene expression up to 3-4 hours [26].  
Recently, it was shown that adding a carbon source (maltose or maltodextrin) 
extends protein synthesis up to 10 hours by activation of the glycolytic pathway [67,68]. 
In this method, the carbon source acts as a substrate for both ATP regeneration and 
recycling of inorganic phosphate. In effect, the phosphate donor and the carbon source 
are used to keep the adenylate energy charge at a sufficient level until protein synthesis 
ceases. This is important, since adding fresh ATP to the solution after a few hours of 
incubation does not work, unless the amount of fresh ATP is large, because the batch 
reaction is inevitably loaded with ADP and AMP. In addition, adding fresh ATP to the 
reaction is complicated since magnesium also has to be added due to the addition of 
negatively charged ATP. The ultimate solution to this problem is to carry out continuous 
buffer exchange through a dialysis membrane against a feeding solution containing the 
nutrients [49,69], or using microfluidics devices either based on diffusion exchange or 
continuous dilution [50,56]. With those setups, cell-free TX-TL reactions can be 
extended from a few hours to at least one day until the TX-TL machineries lose their 
functions. 
While chemical energy is the most important nutrient limitation in run-off 
reactions due to the high demand for translation, other resources can also be limiting. 
Some amino acids, for example, are unstable in cell-free reactions [38]. Additionally, as 
a reaction progresses, the pH decreases (typically from 8 to 6-6.5) due to the 
accumulation of acid-insoluble species, which impacts the entire reaction [70]. For these 
reasons, kinetic models of cell-free TX-TL reactions are performed for the first few hours 
when the reaction is not limited by resources [71-73]. 
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The other resource limitation is the finite concentration of the core TX-TL 
machinery, which is ultimately determined by cellular machinery concentrations. Part of 
this resource limitation is due to the 25-30x dilution factor necessary for the extract 
preparation. The cytoplasmic protein concentration in E. coli cells is on the order of 250-
300 mg/ml [74] making this concentration on the order of 10 mg/ml in typical E. coli cell-
free reactions. This happens to correspond to an optimum for protein synthesis [70]. 
Though no concrete explanations for this particular concentration have been provided, 
E. coli cell-free systems containing more than 10 mg/ml of cytoplasmic extract have 
been tested and are not more productive [75]. 
Cell-free reactions therefore contain fixed concentrations of TX-TL molecular 
machineries, typically 25-30 times less than real E. coli cells: a few tens of nanomolar 
for RNA polymerase, and 1-2 µM ribosomes compared to about 50 µM in living cells 
[49]. For transcription, this dilution is not a problem because most of the cell-free 
systems have T7 RNA polymerase added to the reaction. However, it has been shown 
that the most efficient cell-free system using the endogenous E. coli core RNAP with 
sigma factor 70 (present in the cell extract) for transcription is as efficient as T7-based 
systems [67]. For translation, two regimes are typically observed as a function of added 
DNA template concentration: a linear response and a saturation that occurs at a few 
nanomolar plasmid [26,47,49] (Figure 1). Both the final amount of protein produced and 
the constant protein synthesis rate (determined in the first two hours of expression) 
show those same two regimes. The saturated response, observed using T7 RNA 
polymerase and T7 promoter as well as E. coli transcription with strong promoter-UTR 
pairs, corresponds to a depletion of the TX-TL machineries onto the genetic templates. 
As the plasmid concentration increases, either the RNA polymerase pool is entirely 
sequestered by the input DNA, or the ribosomes pool is entirely sequestered on the 
produced mRNA [76]. Whether it is the transcription or the translation that is limiting 
depends on the type of cell-free system used. In either case, protein synthesis reaches 
a maximum at a specific DNA concentration that is dependent on promoter-UTR 
strength (usually a few nanomolar for strong promoter-UTR pairs such as T7). 
Currently, no ‘metric’ exists with respect to well-defined E. coli regulatory parts to 
compare the transition from linear to saturated regimes between regulatory elements. 
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Technically, this transition is found by expressing eGFP from the promoter-UTR of 
interest and by performing a plasmid titration to determine cell-free expression. This 
allows cell-free users to set plasmids concentrations and know the load on the TX-TL 
core machinery. In cell-free gene network characterization, accelerating mRNA turnover 
[51] to endogenous level (5-6 minutes mRNA mean lifetime in E. coli) prevents 
accumulation of mRNA and saturation of the translation machinery [49]. 
 
5.4 Specific RNA considerations 
 The main consideration when testing RNA networks in TX-TL reactions is the 
presence of RNA degradation machinery (RNases) in the extract. RNA degradation is 
important for RNA network function since the signals that propagate through the 
networks are RNA molecules, which need to degrade in order to control the dynamic 
behavior of the network [62]. Cellular RNases are carried over during extract 
preparation, and their concentrations can very from batch to batch. RNase inhibitors, or 
the E. coli interferase MazF [51], can be used to decrease or increase RNA degradation 
respectively. 
 It is not necessary to tune RNA degradation for all applications, but it is important 
to control for the effects of RNases. For example, in the case of the RNA transcriptional 
repressor (Section 3.1), a no-antisense control plasmid was designed to enable 
comparisons between reactions with and without the antisense RNA plasmid [28]. The 
no-antisense control plasmid has the same promoter as the antisense plasmid driving 
the expression of an RNA transcriptional terminator. A titration of the no-antisense 
control plasmid with 0.5 nM of the attenuator-SFGFP reporter shows that an addition of 
5 nM control plasmid causes an increase in SFGFP production rate (Figure 4B) [28]. 
We hypothesize that this increase is due to competition effects for RNases. While the 
control plasmid does not affect the attenuator in a mechanistic way, the RNA terminator 
can provide a decoy substrate for RNases, in effect stabilizing the attenuator-SFGFP 
reporter mRNA, and leading to an increase in SFGFP production. For most batches, as 
the concentration of the no-antisense control plasmid is increased, the SFGFP 
production rate plateaus once the degradation machinery is saturated (Figure 4B, Batch 
1,3) [28]. This saturation point varies due to batch-to-batch differences in RNase 
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concentration. As a result, it is important to design an appropriate control construct for 
each network being tested, and to use the control to maintain a constant total DNA 
concentration in each reaction that will be compared. 
 
5.5 Specific protein considerations 
When the network being tested in TX-TL reactions expresses proteins, network 
dynamics will be affected by the timescales of both transcription and translation. 
Proteins require time to be translated and to fold, and may form dimers or other 
oligomers. Additionally, protein degradation is dependent on the presence and 
concentration of the protease ClpXP, and requires the protein to be expressed with a 
degradation tag [61]. TX-TL resources such as ATP, GTP and amino acids are also 
consumed by protein production.  
Measurements of transcription and translation rates in TX-TL reveal that both are 
1-2 orders of magnitude slower than in E. coli, due mainly to the 25-30x dilution of TX-
TL machinery in the extract as compared with in vivo conditions [71]. In the first hour of 
a reaction, before resource limitations and reaction waste products become relevant, 
the protein synthesis rate in TX-TL scales linearly with mRNA synthesis dynamics, 
suggesting that transcription rate, not translation rate, limits protein production rate in 
vitro [71]. Protein folding time is variable and protein-specific; the maturation time in TX-
TL of deGFP, a variant of eGFP [23], was measured at 8-8.5 minutes, while that for 
Luciferase, an alternative reporter protein, was less than 1 minute [51].  
 There are small amounts of the ClpXP protease that are endogenous to the cell-
free extract that can degrade ssrA-tagged proteins [51,71]. To test networks that require 
significant protein degradation to function, such as oscillators or feed-forward loops, 
supplemental ClpXP can be added to a reaction through additional DNA templates. 
However, production of ClpXP will require a delay in degradation ability as well as the 
use of TX-TL resources to make the subunits. A viable alternative is to add purified 
synthetically linked hexameric ClpX to the TX-TL reaction [77]. We have found that 
extracts are generally ClpP saturated, and the addition of ClpX alone can increase 
degradation rate to a certain cutoff point. The addition of ClpX alone is relatively 
resource independent [54]. 
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5.6 Negative control fluorescence and subtraction 
 A negative control should be run with each TX-TL experiment. This negative 
control is a mixture of the extract, buffer, and water (instead of network components). 
The fluorescence (or other measured output) of the negative control should be 
measured and subtracted from each time point of the experimental conditions. The 
negative control does display measureable autofluorescence, and in the green 
excitation/emission regime (485 nm/520 nm) this fluorescence decreases over the first 
20-40 minutes after the buffer and extract are mixed together (Supplementary Figure 
S6A). This fluorescence decrease is not seen with every excitation/emission 
combination (Supplementary Figure S6B), and a pre-incubation of the extract and buffer 
for 20-40 minutes at 37oC before adding the network components can eliminate this 
decrease (Supplementary Figure S6A). The time necessary for pre-incubation varies 
with extract batch. A likely hypothesis for this fluorescence decrease is that the 
autofluorescence observed in the green regime is due to the presence of oxidized 
flavin-containing molecules, which have a maximum absorbance near 450 nm [78]. The 
decrease in fluorescence noted above may therefore be caused by the reduction of 
flavins upon mixing extract and buffer, the latter of which is highly reducing 
(Supplementary Figure S6C). Besides altering background fluorescence, there is no 
evidence to indicate that flavin oxidation state affects overall network performance.  
 
5.7 Converting TX-TL results to in vivo results 
 
An important aspect of TX-TL systems that is beginning to be explored is its use 
to transition prototyped networks from in vitro to in vivo. There have already been a 
handful of demonstrations showing that parts and networks prototyped and optimized in 
TX-TL function similarly when ported to cells. These include panels of transcriptional 
and translational units [25,47], the transformation of an extension of the RNA cascade 
reviewed in Section 3.1 [28], and recent success in prototyping and transitioning novel 
negative feedback protein oscillators [27].  
In addition to characterizing RNA transcription cascade response times (Section 
4), we recently used TX-TL reaction spike experiments to test parts required to build a 
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new network called an RNA single input module (SIM). The RNA SIM is an extension of 
the transcription cascade configured to dynamically stage the expression of two proteins 
instead of one [28]. Two additional parts were required to build the RNA SIM. The first 
was a construct that placed two copies of the pT181 attenuator in tandem, upstream of 
the SFGFP coding sequence. This increases the response time of a cascade by making 
the bottom level more sensitive to antisense concentration. The second was a construct 
that would allow for activation of the top level of the cascade with an inducer that could 
be used for in vivo spike experiments. In this case, we used an antisense RNA fused to 
the theophylline aptamer that was engineered to only be functional in the presence of 
theophylline [79].  
To prototype this new theophylline-activated RNA cascade, we first performed a 
DNA spike experiment in TX-TL reactions to show that an RNA cascade using the 
double attenuator construct for L1 indeed had a slower response time (~20 min) than 
the cascade in Section 4 [28]. We then replaced L3 with the theophylline responsive 
antisense and performed a theophylline spike experiment in TX-TL reactions to mimic 
an in vivo theophylline spike experiment (Figure 5A,B). These spike experiments 
showed that an RNA SIM was feasible and the full RNA SIM network was built from 
these parts. A theophylline spike experiment showed that the complete RNA SIM 
functioned in vivo [28], and a comparison of the response time for the double attenuator 
construct in the SIM (Figure 5C) was remarkably similar to the response time from the 
theophylline spike experiment done in TX-TL reactions (Figure 5B). Similar agreement 
was observed when comparing the oscillation periods of ring oscillators prototyped in 
TX-TL reactions and further characterized in vivo [27]. 
These initial findings indicate that transitioning prototyped networks from in vitro 
to in vivo are possible, and that transcriptional and translational units should transition 
when on plasmid DNA. For further predictability, recently developed tools for 
standardizing transcriptional and translational strength in vivo should also be helpful in 
vitro. These include panels of benchmarked synthetic promoter strengths [80,81] and 
predictive bi-cistronic device ribosome binding sites [82]. 
There are several additional considerations that need to be addressed when 
transitioning networks in vivo. To start, one needs to consider putting network units on 
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plasmids with compatible origins of replication and antibiotic resistances, or integrating 
networks genomically into the DNA. This limits networks to set copy numbers, which 
need to be experimentally determined.  Additionally, the stability of both the DNA 
(avoiding hairpins) and of the actual product (toxicity of network components) needs to 
be considered. For example, while Niederholtmeyer et al. found that while TX-TL 
reactions served as a suitable prototyping environment for complex oscillator networks, 
cellular toxicity effects were not captured [27]. While high expressing DNA may be best 
for prototyping in vitro, the cellular load induced in vivo may be detrimental to cellular 
health, requiring re-adjustment of transcriptional and translational unit strength [83,84]. 
Finally, if large timescales are required to test complex networks, devices that emulate 
cellular steady-state behavior with TX-TL reactions, can be used to more accurately 
mimic the in vivo environment. For example, microfluidic reactors can be used to 
exchange TX-TL reagents at dilution rates that match the rates of dividing bacteria 
[27,56]. 
 
 
Figure 5. Comparing in vitro and in vivo response times. (A) Schematic of a modification to the RNA 
transcriptional cascade in Figure 2E. L1 of the cascade was modified to contain tandem attenuators (Att-
1-Att-1) controlling SFGFP production. L3 was replaced with AS-2 fused to a theophylline aptamer (AS-2-
theo) from Qi et al. [79]. AS-2-theo is only active in the presence of theophylline. (B) TX-TL (in vitro) spike 
experiment. L1 (Att-1- Att-1, 0.5 nM) + L2 (4 nM) + aptamer L3 (14 nM) reaction was setup for 20 min at 
which point theophylline (final concentration 2 mM, purple curve) or ddH2O (red curve) was spiked into 
the reaction and time reset to 0. Plot shows normalized fluorescence curves combining three separate 
experiments performed at 37°C with a total of 9 replicates over multiple days. Inset shows that the 
response time of the circuit to the addition of theophylline (τ = 45.2 ± 11.7 min) is slower than the 
response time from a DNA spike due to the aptamer antisense used for L3 [28]. Shaded regions 
represent standard deviations calculated at each time point. (C) In vivo spike experiment. An extension of 
the cascade in A where each level of the cascade was encoded on a separate plasmid, with L1 
containing both Att-1-RFP and Att-1-Att-1-SFGFP, and co-transformed into E. coli TG1 cells. Cultures 
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were grown to exponential growth, and then split. Theophylline was added to one of the split cultures 
once in logarithmic growth at which point time was set to zero. Plot shows normalized fluorescence 
curves with (+) and without (-) theophylline at 2 mM. The response time, τ, for Att-1-Att-1-SFGFP was 
calculated by determining the time at which the (+) and (-) curves were statistically different (τ = 40.0 ± 
9.5 min). Shaded regions represent standard deviations calculated from 12 biological replicates at each 
time point. Figure adapted from Takahashi et al. ACS Synth. Biol., 4 (2015) 503-515 [28]. 	  
6. Catalog of parts tested 
A variety of parts and networks have been demonstrated to function in TX-TL, showing 
the versatility of the platform. The following table is a catalog of parts/networks that 
have been tested in TX-TL with references for characterization information. 
Part Description References 
Reporter protein Used to measure gene expression or 
network output. (eGFP, deGFP, deCFP, 
Luciferase) 
[23,47,49,71,76] 
SsrA-tagged 
reporter protein 
SsrA tag marks proteins for degradation by 
ClpXP (other degradation tags were also 
tested). ClpXP protein or DNA must be 
added to TX-TL reactions separately. 
(eGFP-ssrA) 
[23,71] 
E. coli sigma 
factors 
Alternative transcriptional activation units. 
(σ19, σ24 , σ28, σ32, σ38, σ54, NtrC). 
[49] 
Protein 
transcriptional 
repressors and 
activators 
Allows for inducible transcriptional 
repression or activation. (TetR, LacI, AraC, 
lambda repressors Cl and Cro) 
[47,49] 
Fusion protein  Provides a fluorescent output to monitor 
TetR production. (TetR-deGFP) 
[22] 
Constitutive 
promoters 
Provides constant transcription from the 
start of the reaction. (Pr, Pr1, Pr2) 
[76] 
Malachite green 
aptamer 
Fluoresces when the malachite green dye 
is added to TX-TL reactions. Useful for 
optically quantifying RNA levels. 
[76] 
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T3, T7 RNA 
polymerase 
Allows for transcription from bacteriophage 
T3 and T7 promoters. 
[49,76] 
RNA 
transcriptional 
attenuator 
Antisense RNA mediated transcriptional 
repressor.  
[28] 
Small 
transcription 
activating RNAs 
(STARs) 
Small RNAs that activate the transcription 
of a specific gene regulated by a 
terminator. (T181, AD1)   
[85] 
 
Network Description References 
Bistable switch Switches between two states regulated by 
the lactose and tetracycline regulated 
promoters.  
[49] 
Ring oscillator Three, four, and five-node protein mediated 
ring oscillators. 
[27] 
RNA 
transcription 
cascade 
A three-level RNA transcription cascade. [28] 
RNA Single 
Input Module 
Dynamically controls the expression of two 
genes with one master regulator. 
[28] 
  
7. Applications  
Cell-free protein synthesis was originally developed to address fundamental 
questions related to the genetic code and transcription regulation [86,87]. In the last 
twenty years, this technology has become powerful and versatile enough to be brought 
to the industrial level [88] for the production of gram quantities of proteins in huge 
reactions volumes (liters, or hundred of liters). At the same time, cell-free expression 
has become a popular tool in laboratories where many new applications and assays are 
created in the research areas of medicine, nanotechnology, cell-free biology, chemical 
and metabolic engineering [32,89-91]. Cell-free TX-TL reactions can also be carried out 
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in cell-sized compartments and in microfluidics devices for high-throughput applications. 
The first major step in this transition was the production of high yield E. coli-based in 
vitro protein synthesis systems. Understanding the complex biochemical processes 
behind TX-TL was critical to achieve enough protein synthesis in batch mode reactions 
so that useful applications could be envisioned [88]. Beyond TX-TL molecular 
machineries, endogenous enzymes in E. coli cytoplasmic extracts can be used to 
energize cell-free reactions and reach concentrations of one or a few milligrams per 
milliliter of soluble proteins [35]. A considerable reduction of the reaction mixture and 
procedure costs was also achieved, which was essential for commercialization and 
large-scale production. 
This work fostered the development of new methods to energize cell-free 
reactions. Glycolytic intermediates and carbon sources are used to sustain energy 
regeneration for longer time periods and help recycle inhibitory byproducts of reactions 
[37,67,68]. This area of research is advancing rapidly, with new energy mixtures for E. 
coli cell-free TX-TL systems proposed almost every year. Yet, these platforms are 
limited to cytoplasmic bacterial proteins that do not necessitate specific folding 
conditions or post-translational modification. Another major step was to demonstrate 
that complex eukaryotic proteins containing disulfide bonds can be produced in large 
amounts using E. coli extracts [92], leading to the large scale production of antigen and 
antibodies using cell-free expression. At least two companies have specialized in cell-
free protein synthesis for medicine and novel therapeutics, Sutro Biopharma Inc 
(www.sutrobio.com) and Exix Bio (www.exixbio.com). As boundary-free systems, 
screening of hundreds of protein variants with cell-free systems is another promising 
avenue to personalized medicine. 
In the past decade, cell-free TX-TL has become within the reach of individual 
research labs. As a result, a myriad of applications have been created that do not 
require industrial levels of production or large reaction volumes. For example, protein 
evolution, developed in the 90s, has taken advantage of high yield cell-free systems as 
well as miniaturization and high-throughput techniques [93]. On the medical side, cell-
free TX-TL systems are becoming useful for the synthesis of vaccine candidates, for the 
identification of drug candidates and for diagnostics [90]. The recent development of 
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paper-based cell-free TX-TL gene networks to make Ebola sensors and other 
diagnostics [48] is a particularly intriguing example of this new direction, which promises 
to create powerful, low-cost diagnostics with high societal impact. 
TX-TL systems are also being shown to be able to produce far more than single 
proteins. A particularly striking example of this is the complete synthesis of functional 
bacteriophages, such as T7, using only TX-TL reactions and viral genomic DNAs. The 
T7 genome contains about 60 protein coding genes that encode for viral DNA 
replication and assembly, and the synthesis of infective T7 virions in TX-TL reactions 
demonstrates that genome-sized networks and complex self-assembled processes can 
be achieved outside living cells [94]. In a reverse engineering approach, using robust 
cell-free gene networks could help construct purely synthetic nanomachines or new 
materials from natural parts [95,96]. Cell-free TX-TL systems are also expected to 
expand the scope of applications in chemical and metabolic engineering. For example, 
cell-free platforms are now used to optimize biosynthetic pathways for the production of 
therapeutics and fuels [97,98]. 
 
7.1 Cell-free TX-TL systems as an educational platform 
 Recently, the flexibility and ease-of-use of TX-TL systems have been leveraged 
in an educational setting. Specifically, we brought the TX-TL characterization system to 
the inaugural Cold Spring Harbor Synthetic Biology Summer Course (CSHL SynBio) to 
teach aspiring synthetic biologists the principles of genetic network design in the context 
of addressing real research problems. The results were a resounding success – we 
were able to teach four students who had little to no experience in wet lab synthetic 
biology the basics of TX-TL reactions in a matter of days. By the end of the two week 
course, they had performed many of the preliminary experiments that lead to the results 
presented in Section 3.1 (Figure 2) [28]. This remarkable success has continued, with 
an expansion of the use of TX-TL reactions in CSHL SynBio, which is a testament to the 
robustness of the TX-TL platform. By decoupling genetic network characterization from 
cell growth, students can rapidly test their own hypotheses and learn about synthetic 
biology through hands on, immersive design-build-test cycles. We believe that TX-TL 
systems can also be employed in lower-resource educational settings, since simple 
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networks can be designed with green fluorescent outputs that are bright enough to be 
seen with the naked eye under inexpensive blue-light sources. 
 
8. Conclusions 
 Cell-free TX-TL synthetic biology is a rapidly growing research area that spans a 
wide range of applications, from the development of genetic parts to the construction of 
complex self-assembled biological systems [99]. Here we have outlined how the 
simplicity and rapid time scale of TX-TL experiments greatly speeds up the overall 
design-build-test cycle for engineering genetic networks, thus making it an appealing 
system for synthetic biology. To help other researchers adopt this powerful platform, we 
have presented examples and guidelines for using TX-TL reactions to prototype both 
RNA and protein genetic parts and networks. However, many of the guidelines will be 
useful for all TX-TL applications. We anticipate an acceleration in the use of TX-TL 
systems for prototyping and characterizing genetic networks, as well as a whole host of 
new applications that will emerge from this powerful and flexible technology. 
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